BPAP (benzofuranylpropylaminopentane / R-BPAP) is a synthetic catecholaminergic and serotonergic activity enhancer (CAE/SAE) engineered for central nervous system, monoamine release kinetics, and neuroprotection research. Operating at ultra-low picomolar concentrations (10-13 M to 10-12 M), BPAP selectively amplifies impulse-propagation-mediated release of dopamine, norepinephrine, and serotonin (5-HT) without triggering non-vesicular transmitter depletion.
$48.00
In stock
| Quantity | Discounted Price |
|---|---|
| 4 - 6 | $46.08 |
| 7 - 9 | $45.12 |
| 10 + | $44.16 |
| 3 - 5 | $46.08 |
| 5 - 9 | $44.16 |
| 10 + | $42.24 |
BPAP (known chemically as (-)-1-(benzofuran-2-yl)-2-propylaminopentane or R-BPAP) is a novel synthetic derivative of PPAP (phenylpropylaminopentane) and selegiline (deprenyl). Developed as a highly potent catecholaminergic and serotonergic activity enhancer (CAE/SAE), BPAP represents a distinct class that enhances action-potential-stimulated neurotransmitter release rather than acting as a direct monoamine releasing agent or reuptake inhibitor. By modulating impulse-evoked exocytosis at ultra-low picomolar concentrations (10-13 M to 10-12 M), BPAP amplifies physiological signaling across dopaminergic, noradrenergic, and serotonergic neural circuits without depleting intracellular vesicular transmitter pools. Batch-verified for high analytical purity at Modern Aminos, BPAP is supplied in a 100mcg/mL aqueous liquid solution in a 30mL amber glass bottle with a 1mL precision dropper. Laboratories evaluating neuro-restorative signaling, impulse-dependent monoamine dynamics, and anti-apoptotic survival pathways utilize BPAP alongside complementary neuro-energetic reference standards available on the site, such as 9-Me-BC, Bromantane, NSI-189 Phosphate, and Semax.
| Compound Name | BPAP (benzofuranylpropylaminopentane) |
|---|---|
| Quantity / Formats Offered | 100mcg/mL Liquid Solution (30ML Amber Glass Bottle with 1mL Dropper) |
| Synonyms / Alt Names | (-)-BPAP, R-BPAP, Benzofuranylpropylaminopentane, CAE/SAE Activity Enhancer |
| CAS Number | 182150-13-8 (R-Enantiomer) | 142617-31-2 (Free Base) |
| Chemical Formula | C17H25NO |
| Molecular Weight | 259.39 g/mol |
| IUPAC Name | (2R)-1-(1-benzofuran-2-yl)-N-propylpentan-2-amine |
| InChIKey | YVIQZOCVJFYPJS-LBOIARJSSA-N |
| SMILES Code | CCCC(CC1=CC2=CC=CC=C2O1)NCCC |
The biochemical pathways and cellular targets of BPAP in laboratory research include:
When evaluating research efficacy and published scientific literature for BPAP:
To evaluate monoaminergic release kinetics, neuroprotective pathways, and receptor targets, researchers compare BPAP against alternative reference standards available at Modern Aminos:
| Compound / Reference | Chemical Class & Structure | Core Mechanism of Action | Research Focus & Profile |
|---|---|---|---|
| BPAP | Benzofuranylpropylamine Derivative | Enhances impulse-propagation-mediated release of dopamine, norepinephrine, and 5-HT at picomolar levels | Focuses on physiological monoaminergic activity enhancement, neuroprotection against MPP+, and BDNF upregulation |
| 9-Me-BC | Methylated β-Carboline Nootropic | Upregulates Tyrosine Hydroxylase (TH) gene expression and stimulates dopaminergic neurite outgrowth | Focuses on dopaminergic neuron structural restoration, tyrosine hydroxylase induction, and respiratory Complex I support |
| Bromantane | Synthetic Adamantane Actoprotector | Induces Tyrosine Hydroxylase (TH) and AAAD gene transcription while modulating GABAergic neurotransmission | Focuses on non-depleting dopaminergic biosynthesis, actoprotective physical/mental endurance, and non-sedating anxiolysis |
| NSI-189 Phosphate | Benzylpiperazine Aminopyridine Complex | Stimulates neurogenesis and synaptic arborization in the hippocampal dentate gyrus | Focuses on hippocampal volume expansion, neurogenesis, and structural neuroplasticity rather than direct monoamine release |
DISCLAIMER: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). No products are approved for oral, sublingual, nor in vivo use. These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.